Pular para o conteúdo
Merck

Intravital imaging of neutrophil recruitment in hepatic ischemia-reperfusion injury in mice.

Transplantation (2013-02-21)
Masaki Honda, Takayuki Takeichi, Katsuhiro Asonuma, Koji Tanaka, Masato Kusunoki, Yukihiro Inomata
RESUMO

Neutrophils are considered responsible for the pathophysiologic changes during hepatic ischemia-reperfusion (I/R) injury; however, few studies have examined real-time intravital neutrophil recruitment. Here, we show a method for imaging the neutrophil recruitment in hepatic I/R injury using two-photon laser scanning microscopy (TPLSM). LysM-eGFP mice were subjected to 45 min of partial warm hepatic ischemia followed by reperfusion. Mice received an intravenous injection of tetramethylrhodamine isothiocyanate-labeled albumin to visualize the microvasculature. Using time-lapse TPLSM technique, we directly observed the behavior of neutrophils in I/R injury. At low magnification, four to six hepatic lobules could be visualized. The number of adherent neutrophils continued to increase for 4 hr after reperfusion, whereas their crawling velocity reached a maximum of 2 hr after reperfusion and then decreased gradually. High-magnification images revealed the presence or absence of blood circulation in sinusoids. Six hours after control operation or reperfusion, circulation was maintained in all sinusoids in the control group, whereas spotty nonperfused areas accompanied by neutrophil infiltration could be observed in the I/R group. Adherent neutrophils in perfused areas in the I/R group had more elongated shapes and moved more quickly than those in nonperfused areas and in the control group. Some hepatocytes affected by I/R injury showed the changes in their size and fluorescent intensity, which could attract neutrophils. TPLSM was successfully used for intravital imaging of hepatic I/R injury in mice and has potential for a wide range of applications to investigate the mechanism of I/R injury.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Lisozima, powder or granules, ≥90 %, ≥39,000 units/mg protein
Sigma-Aldrich
Lisozima, BioUltra, lyophilized powder, ≥98% (SDS-PAGE), ≥40,000 units/mg protein
Sigma-Aldrich
Lysozyme human, Lysobac, recombinant, expressed in rice, ≥100,000 units/mg protein, lyophilized powder
Sigma-Aldrich
Lisozima, 10 mg/mL
Sigma-Aldrich
Lysozyme chloride form from chicken egg white, Grade VI, ≥35,000 units/mg protein (E1%/282)
Sigma-Aldrich
Lisozima, powder (crystalline), 70000-140000 U/mg
Sigma-Aldrich
Lisozima, For use as a marker in SDS-PAGE
Sigma-Aldrich
Lisozima, aseptically filled
Sigma-Aldrich
Lysozyme from human neutrophils, ≥95% (SDS-PAGE), lyophilized powder, ≥100,000 units/mg protein (E1%/280)
Sigma-Aldrich
Lisozima, dialyzed, lyophilized, powder, ~100000 U/mg
Supelco
Lisozima, VETRANAL®, analytical standard